TY  - GEN
AU  - Vickers,Mark A
AU  - Wilkie,Gwen M
AU  - Robinson,Nicolas
AU  - Rivera,Nadja
AU  - Haque,Tanzina
AU  - Crawford,Dorothy H
AU  - Barry,Jacqueline
AU  - Fraser,Neil
AU  - Turner,David M
AU  - Robertson,Victoria
AU  - Dyer,Phil
AU  - Flanagan,Peter
AU  - Newlands,Helen R
AU  - Campbell,John
AU  - Turner,Marc L
TI  - Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease
SN  - 1365-2141
PY  - 2014///1215
KW  - Adolescent
KW  - Allografts
KW  - Central Nervous System Neoplasms
KW  - therapy
KW  - Child, Preschool
KW  - Epstein-Barr Virus Infections
KW  - immunology
KW  - Female
KW  - HLA Antigens
KW  - analysis
KW  - Herpesvirus 4, Human
KW  - Histocompatibility Testing
KW  - Humans
KW  - Immunotherapy, Adoptive
KW  - Infant
KW  - Leiomyosarcoma
KW  - Licensure
KW  - Lung Neoplasms
KW  - Lymphoproliferative Disorders
KW  - etiology
KW  - Male
KW  - Middle Aged
KW  - New Zealand
KW  - Postoperative Complications
KW  - Remission Induction
KW  - Sarcoma
KW  - T-Cell Antigen Receptor Specificity
KW  - T-Lymphocytes, Cytotoxic
KW  - Tissue Banks
KW  - organization & administration
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/bjh.13051
ER  -